Preparation and application of graded frozen micro-needle patch delivery nano-drug

By delivering nanomedicines via graded cryo-microneedle patches, the problems of systemic toxicity and poor patient compliance in tumor treatment have been solved. This approach achieves efficient drug aggregation and photochemical synergistic therapy in the tumor area, significantly improving treatment efficacy.

CN119015208APending Publication Date: 2024-11-26UNIV OF SHANGHAI FOR SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411169814.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-25
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing cancer treatment methods suffer from systemic toxicity, reduced efficacy, and poor patient compliance. In particular, during phototherapy, traditional transdermal delivery methods are difficult to effectively improve drug accumulation and treatment efficacy in the tumor area.

Method used

A graded cryogenic microneedle patch was used to deliver nanomedicines. By preparing metalloporphyrin complex nanomedicines and methacrylated gelatin hydrogels, combined with low-temperature microforming technology, a microneedle patch capable of efficiently accumulating in the tumor region and altering the redox state was prepared.

Benefits of technology

This method enables local delivery of nanomedicines, reduces systemic phototoxicity, improves targeting and therapeutic efficacy, significantly enhances photochemical synergistic therapeutic effects, and has a simple and convenient preparation process suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015208A_ABST
    Figure CN119015208A_ABST
Patent Text Reader

Abstract

The invention discloses preparation and application of a graded frozen micro-needle patch delivery nano-drug, the preparation comprises preparation of the nano-drug, preparation of GelMA hydrogel and preparation of a graded methacrylic acid gelatin micro-needle patch loaded with the nano-drug, and the prepared micro-needle patch is a square with the size of 1 cm and provided with 11 * 11 micro-needles with the height of 800 m. The method has the advantages that the nano-drug is locally delivered through a low-temperature micro-forming technology, so that the phototoxicity of the whole body is reduced, the pain is reduced, and the targeting property is enhanced; the photochemical co-therapeutic agent can rapidly gather to a tumor area, can change the TEM oxidation-reduction state of the tumor, consumes GSH, enhances ROS, and significantly improves the photochemical co-therapeutic effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of anti-tumor drugs, and in particular to the preparation and application of a graded freezing microneedle patch for delivering nano drugs. Background Art

[0002] In order to reduce the systemic toxicity of tumor treatment and improve the therapeutic effect, designing precise and minimally invasive drug delivery methods is one of the current research directions for tumor treatment. Traditional transdermal delivery methods usually include intravenous injection, intratumoral injection, ion infiltration, and nanoemulsion methods, but these methods usually cause systemic toxicity during phototherapy, reduce drug efficacy during delivery, and have poor patient compliance, limiting a wider range of applications.

[0003] Typically, the tumor microenvironment (TME) exhibits a unique redox imbalance characterized by overexpression of hydrogen peroxide and the antioxidant GSH and weak acidity. This imbalance often reduces the efficacy of PDT against tumors because GSH can effectively neutralize reactive oxygen species (ROS), which are essential for PDT-induced apoptosis. Conversely, reducing excess GSH levels within the TME can lead to the accumulation of ROS at the tumor site, thereby promoting apoptotic pathways and significantly improving PDT effectiveness. Therefore, regulation of ROS-GSH redox balance has become a key strategy to enhance cancer treatment outcomes. This is where the present application needs to focus on improvement. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a preparation and application of a graded cryo-microneedle patch for delivering nano-drugs, improve targeting, minimally invasively and efficiently concentrate drugs in the tumor area, and synergistically fight tumors through photochemical power to improve the therapeutic effect.

[0005] In order to solve the above technical problems, the present invention provides a preparation method for delivering nanomedicines by graded cryo-microneedle patches, comprising the following steps: Step S1: Preparation of nanomedicine: Porphyrin is selected as ligand, Cu 2+ ,Fe 3+ ,Co 2+ The metal atom is coordinated to form a metal porphyrin complex. The synthesis methods of Cu(Ⅱ)-TCPP, Fe-TCPP and Co-TCPP are similar. TCPP is a tetradentate ligand and is coordinated with the corresponding metal salt (CuCl 2 、FeCl 3 、Co(NO 3 ) 2 ) reaction, prepared by solution synthesis or hydrothermal or solvothermal method; the specific preparation of nano drug is as follows: 1) Preparation of Cu(Ⅱ)-TCPP two-dimensional nanomedicine: ① Dissolve 80 mg of porphyrin in 40 mL of solution A and stir continuously until the solution becomes clear; The solution A is dimethylformamide DMF:n-hexane (v:v) = 3:1; ② Add 400 mg CuCl 2 Dissolve 2H2O in 40 mL of anhydrous ethanol and stir for 10 minutes; ③ Mix the two solutions and stir for 20 to 40 minutes, then place them in a water bath at 80 to 90°C and stir for 10 to 15 hours; Preferably, the mixture is stirred for 30 minutes and heated in a water bath at 85°C for 12 h; ④ Wash the solution alternately with anhydrous ethanol and deionized water for 3 times at 8000 rmp; ⑤ Perform ultrasonic peeling at 5-10°C for 1-2h, high-speed centrifugation for 15 min (12000 rmp), wash with deionized water 3 times, disperse it in deionized water, freeze it in a refrigerator for 6-10h, and freeze-dry it in a freeze dryer to obtain sheet-like Cu(Ⅱ)-TCPP nanomedicine; Preferentially, ultrasonic stripping was performed at 5°C for 1.5 h and the freezing time was 8 h; 2) Preparation of Fe-TCPP nanomedicine: ① Use dimethylformamide DMF as solvent to prepare three solutions: 4 mL solution B: 60 mg FeCl 3 6H 2 0; 8 mL solution C: 20 mg porphyrin; 8 mL of solution D: 560 mg benzoic acid; ② Mix and stir the three prepared solutions for 30 min, and then place them in a water bath at 80-100°C and stir for 4-7 h; Preferably, stirring in a 90°C water bath for 5 h; ③ After the reaction, the solution was centrifuged at high speed for 15 min (12000 rmp), washed with deionized water three times, and dispersed in deionized water; 3) Preparation of Co-TCPP nanomedicine: ①Co(NO 3 ) 2 6H 2O (16.16 mg), 2,2'-bipyridine BPY (6.2 mg) and PVP (40 mg) were completely dissolved in a mixture of dimethylformamide DMF (18 mL) and ethanol (6 mL), and the mixed solution was placed in a 50 mL glass bottle; ② TCPP (16 mg) was completely dissolved in a mixture of DMF (6 mL) and ethanol (2 mL), and then added dropwise to the above glass bottle; ③Ultrasonic treatment for 25-35 min, Preferably, the ultrasonic treatment time is 30 min; ④ Heat the mixture to 70-90°C and stir while maintaining the temperature for 20-24 hours; Preferably, stirring at 80°C for 24 h, ⑤ After cooling to room temperature, the crude product was centrifuged and washed with ethanol three times, and the obtained Co-TCPP nanosheets were redispersed in ethanol.

[0006] Step S2: Preparation of methacrylated gelatin (GelMA) hydrogel: ① Dissolve 5 g of gelatin in 50 mL of phosphate buffered saline (PBS) and stir at 50-70°C for 2-4 h; Preferably, stirring at 60 °C for 3 h; ② Add 10 mL of methacrylic anhydride (MA) solution to the above solution at a rate of 0.3-0.6 mL / min and stir at 40-60°C for 2-4 h; Preferably, 10 mL of methacrylic anhydride (MA) solution was added at a rate of 0.5 mL / min and stirred at 50 °C for 3 h; ③ Add 250 mL of room temperature phosphate buffer PBS to dilute all the mixtures to stop the methacrylic acidification reaction; finally, dialyze with a dialysis bag (molecular weight cutoff 8-14 kDa) for 5-7 days; deionized water was replaced every 12 hours, and methacrylated gelatin (GelMA) hydrogel was successfully prepared; Preferably, the dialysis is performed using a dialysis bag (molecular weight cut-off 8-14 kDa) for 6 days.

[0007] Step S3: Preparation of hierarchical methacrylated gelatin microneedle patches loaded with nanodrugs; ① Prepare a solution with a mass fraction of 0.32 wt% to 0.4 wt% by dissolving 4 to 5 mg of the nanodrug prepared in step S1 in 1.25 mL of the GelMA hydrogel solution prepared in step S2, and stir at a low temperature of 2 to 8°C until the mixture is uniformly stirred; Preferably, stir well at 4°C; ② Then inject it into the microneedle mold made of polydimethylsiloxane (PDMS), place it symmetrically in a 6-well plate, and then centrifuge it at 3500 rpm for 5 min in a low-temperature shaker at 2-8°C. Rotate the 6-well plate 180° clockwise and centrifuge it again to fill the needle tip with nanomedicine. Remove the excess solution of the base with a pipette, and then add the GelMA hydrogel solution to serve as the microneedle base. Preferably, centrifuge at 3500 rpm for 5 min in a 4°C low-temperature shaker; ③ Place the microneedle patch under 405 nm ultraviolet light for cross-linking for 2 to 5 minutes; Preferably, crosslinking was performed under 405 nm UV light for 3 min. ④Then place it in liquid nitrogen and freeze it for 15 to 30 minutes; Preferably, freeze in liquid nitrogen for 20 min. ⑤ After demoulding, refreeze for 20 to 40 seconds, preferably 30 seconds, to improve mechanical properties; The prepared microneedle patch was 1 cm square, with 11×11 microneedles with a height of 800 µm.

[0008] The superior effects of the present invention are: 1) The present invention uses graded cryo-microneedle patches to deliver nano-drugs for photochemical synergistic anti-tumor effects. Graded cryo-microneedle patches use low-temperature micro-molding technology to locally deliver nano-drugs, reduce systemic phototoxicity, and do not require any syringes. The patch type is more convenient and safe, reduces pain, and enhances targeting. 2) The nanomedicine of the present invention can not only quickly accumulate in the tumor area, but also change the tumor TEM redox state, consume GSH, enhance ROS, and significantly improve the photochemical synergistic treatment effect; 3) The preparation process of the present invention is fast, convenient and low-cost, which is conducive to large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] The drawings constituting a part of the present application are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings: Figure 1 This is a schematic diagram of the preparation of Cu-TCPP nanomaterials according to a specific embodiment of the present invention; Figure 2 This is a schematic diagram of the preparation of GelMA cryo-microneedles loaded with Cu-TCPP nanodrugs according to a specific embodiment of the present invention; Figure 3This is a schematic diagram of the mechanism of GelMA cryo-microneedles loaded with Cu-TCPP nano-drugs in a tumor microenvironment according to a specific embodiment of the present invention; Figure 4 This is a schematic diagram of the in vivo treatment of melanoma mice with GelMA cryo-microneedles loaded with Cu-TCPP nanomedicine according to a specific embodiment of the present invention; Figure 5 This is a curve diagram of the release rate and release amount of a frozen microneedle patch and a normal room temperature HA microneedle patch using rhodamine B as a simulated drug in a specific embodiment of the present invention. DETAILED DESCRIPTION

[0010] The embodiments of the present invention are described in detail below with reference to the accompanying drawings.

[0011] The present invention provides a preparation method of a graded cryo-microneedle patch for delivering nano-drugs, and application of the same in the tumor inhibition effect in melanoma-bearing mice. Embodiment 1:

[0012] Taking Cu-TCPP as an example, the preparation of the GelMA cryo-microneedle patch loaded with Cu-TCPP is specifically described, including the following steps: Step S1: Preparation of Cu(Ⅱ)-TCPP two-dimensional nanomedicine: ① Dissolve 80 mg of porphyrin in 40 mL of solution A and stir continuously until the solution becomes clear; The solution A is dimethylformamide DMF:n-hexane (v:v) = 3:1; ② Add 400 mg CuCl 2 Dissolve 2H2O in 40 mL of anhydrous ethanol and stir for 10 minutes; ③ Mix the two solutions and stir for 30 minutes, then place them in a water bath at 85℃ and stir for 12 hours; ④ Wash the solution alternately with anhydrous ethanol and deionized water for 3 times at 8000 rmp; ⑤ Ultrasonic stripping was performed at 5°C for 1.5 h, high-speed centrifugation was performed for 15 min (12000 rmp), and deionized water was washed three times, dispersed in deionized water, frozen in a refrigerator for 8 h, and freeze-dried in a freeze dryer to obtain sheet-like Cu(Ⅱ)-TCPP nanomedicine; preparation method Figure 1 As shown, Cu(Ⅱ)-TCPP two-dimensional nanosheets were obtained by ultrasonic exfoliation.

[0013] Step S2: Preparation of methacrylated gelatin (GelMA) hydrogel: Firstly, 5 g of gelatin was dissolved in 50 mL of PBS and stirred at 60°C for 3 h. Then, 10 mL of methacrylic anhydride (MA) solution was added at a rate of 0.5 mL / min and stirred at 50°C for 3 h. Then, 250 mL of room temperature PBS was added to dilute all the mixtures to stop the methacrylation reaction. Finally, the mixture was dialyzed with a dialysis bag (molecular weight cutoff 8-14 kDa) for 6 days. The deionized water was replaced every 12 h. Methacrylated gelatin (GelMA) hydrogel was successfully prepared.

[0014] Step S3: Preparation of hierarchical methacrylated gelatin microneedle patch loaded with Cu(Ⅱ)-TCPP two-dimensional nanodrug: Dissolve 4.5 mg of Cu(Ⅱ)-TCPP two-dimensional nanodrug in 1.25 mL of GelMA hydrogel solution, stir at 4℃ until evenly stirred, inject into the microneedle mold made of PDMS, place it symmetrically in a 6-well plate, then centrifuge at 3500 rpm for 5 min in a 4℃ low-temperature shaker, rotate the 6-well plate 180° clockwise and centrifuge again to fill the Cu(Ⅱ)-TCPP nanodrug into the needle tip, remove the excess solution of the base with a pipette, and then add GelMA hydrogel solution to serve as the microneedle base; place the microneedle patch under 405 nm ultraviolet light for crosslinking for 3 min; then place it in liquid nitrogen and freeze it for about 20 min, and refrozen it for 30 s after demolding to improve the mechanical properties. The preparation diagram is shown in the figure below. Figure 2 shown.

[0015] The prepared microneedle patch is 1 cm square, with 11×11 microneedles with a height of 800 µm. This size of microneedle patch is very beneficial for patients, which can reduce their pain and improve their compliance.

[0016] Layered cryogenic microneedles were used to promote the release of ultrathin two-dimensional Cu(Ⅱ)-TCPP as a nanodrug. The layered cryogenic microneedle patch penetrated the skin barrier and melted rapidly without producing much residual material, enabling the precise and biocompatible delivery of Cu(Ⅱ)-TCPP to the tumor site. Figure 3 As shown, in the TME, which has low pH, high concentrations of glutathione and hydrogen peroxide, Cu(Ⅱ)-TCPP nanomedicine catalyzes oxygen to produce singlet oxygen under laser irradiation, and can also consume glutathione to become Cu(Ⅰ)-TCPP, which catalyzes hydrogen peroxide to produce hydroxyl radicals. Reducing the level of excess GSH in the TME can lead to the accumulation of ROS at the tumor site, thereby promoting the apoptotic pathway and significantly improving the effectiveness of PDT. Therefore, the regulation of ROS-GSH redox balance has become a key strategy to enhance the results of cancer treatment. Embodiment 2:

[0017] The preparation of the Fe-TCPP-loaded GelMA cryo-microneedle patch includes the following steps: 1. Preparation method of Fe-TCPP nanomedicine: Prepare 4 mL of solution A using DMF as solvent: 60 mg FeCl 3 6H 2 0, 8 mL solution B: 20 ​​mg porphyrin, 8 mL solution C: 560 mg benzoic acid, the prepared solutions were mixed and stirred for 30 min, then placed in a 90°C water bath and stirred for 5 h. After the reaction, the solution was centrifuged at high speed for 15 min (12000 rmp), washed with deionized water 3 times, and dispersed in deionized water.

[0018] 2. Preparation of methacrylated gelatin (GelMA) hydrogel: Firstly, 5 g of gelatin was dissolved in 50 mL of PBS and stirred at 60°C for 3 h. Then, 10 mL of methacrylic anhydride (MA) solution was added at a rate of 0.5 mL / min and stirred at 50°C for 3 h. Then, 250 mL of room temperature PBS was added to dilute all the mixtures to stop the methacrylation reaction. Finally, the mixture was dialyzed with a dialysis bag (molecular weight cutoff 8-14 kDa) for 6 days. The deionized water was replaced every 12 h. Methacrylated gelatin (GelMA) hydrogel was successfully prepared.

[0019] 3. Preparation of hierarchical methacrylated gelatin microneedle patches loaded with Fe-TCPP nanodrugs: 4.5 mg of Fe-TCPP nanodrug was dissolved in 1.25 mL of GelMA hydrogel solution, stirred at 4°C until uniform, and injected into the microneedle mold made of PDMS, which was symmetrically placed in a 6-well plate, and then centrifuged at 3500 rpm in a 4°C low-temperature shaker for 5 min. The 6-well plate was rotated 180° clockwise and centrifuged again to fill the Fe-TCPP nanodrug to the needle tip. The excess solution of the base was removed with a pipette, and then the GelMA hydrogel solution was added to serve as the microneedle base; the microneedle patch was placed under 405 nm ultraviolet light for crosslinking for 3 min; then it was placed in liquid nitrogen and frozen for about 20 min, and then re-frozen for 30 s after demolding to improve the mechanical properties. The prepared microneedle patch is 1 cm square with 11×11 microneedles with a height of 800 µm. Embodiment 3:

[0020] The preparation of the Co-TCPP-loaded GelMA cryo-microneedle patch includes the following steps: 1. Preparation of Co-TCPP nanomaterials: Co(NO 3 ) 2 6H 2 O (16.16 mg), 2,2'-bipyridine (2,2'-Bipyridine) (6.2 mg) and PVP (40 mg) were completely dissolved in a mixture of DMF (18 mL) and ethanol (6 mL) and placed in a 50 mL glass bottle; at the same time, TCPP (16 mg) was completely dissolved in a mixture of DMF (6 mL) and ethanol (2 mL), then added dropwise to the above glass bottle and ultrasonically treated for 30 min; finally, the mixture was heated to 80 ° C and stirred for 24 h. After cooling to room temperature, the obtained crude product was centrifuged and washed with ethanol three times. Finally, the obtained Co-TCPP nanosheets were redispersed in ethanol.

[0021] 2. Preparation of methacrylated gelatin (GelMA) hydrogel: Firstly, 5 g of gelatin was dissolved in 50 mL of PBS and stirred at 60°C for 3 h. Then, 10 mL of methacrylic anhydride (MA) solution was added at a rate of 0.5 mL / min and stirred at 50°C for 3 h. Then, 250 mL of room temperature PBS was added to dilute all the mixtures to stop the methacrylation reaction. Finally, the mixture was dialyzed with a dialysis bag (molecular weight cutoff 8-14 kDa) for 6 days. The deionized water was replaced every 12 h. Methacrylated gelatin (GelMA) hydrogel was successfully prepared.

[0022] 3. Preparation of hierarchical methacrylated gelatin microneedle patches loaded with Co-TCPP nanodrugs: 4.5 mg Co-TCPP nanodrug was dissolved in 1.25 mL GelMA hydrogel solution, stirred at 4°C until uniform, and injected into the microneedle mold made of PDMS, which was placed symmetrically in a 6-well plate, and then centrifuged at 3500 rpm in a 4°C low-temperature shaker for 5 min. The 6-well plate was rotated 180° clockwise and centrifuged again to fill the Co-TCPP nanodrug into the needle tip. The excess solution of the base was removed with a pipette, and then the GelMA hydrogel solution was added to serve as the microneedle base; the microneedle patch was placed under 405 nm ultraviolet light for crosslinking for 3 min; then it was placed in liquid nitrogen and frozen for about 20 min, and then re-frozen for 30 s after demolding to improve the mechanical properties. The prepared microneedle patch is 1 cm square with 11×11 microneedles with a height of 800 µm.

[0023] GelMA cryo-microneedle patch can achieve rapid drug delivery and residue-free delivery. Compared with the release rate and amount of hyaluronic acid microneedle patch at room temperature, using rhodamine B as a model drug, Figure 5 It was concluded that the frozen microneedle patch can achieve rapid and efficient delivery of nanomedicine within 30 minutes.

[0024] Then, B16F10 cells were injected into the hind legs of C57BL / 6 mice to establish a mouse melanoma model. Figure 4 As shown in the schematic diagram, when the tumor volume reached about 35 mm³, the tumor-bearing mice were randomly divided into 4 groups, with 6 mice in each group, and the average tumor size in each group was about 35 mm³. The experiment divided the tumor-bearing mice into 4 groups (control group, laser group, graded cryomicroneedle patch treatment group, graded cryomicroneedle patch + laser group), and the four groups of mice were treated and observed for 2 weeks. As can be seen from Table 1, the weight of the mice remained stable throughout the treatment period, and the overall health was good. According to the measured tumor volume during the treatment of mice, the laser group and the GelMA cryomicroneedle group loaded with Cu(Ⅱ)-TCPP nanodrug had limited inhibitory effects on melanoma compared with the control group, while the GelMA cryomicroneedle + laser treatment group loaded with Cu(Ⅱ)-TCPP nanodrug showed the most obvious inhibitory effect on melanoma growth compared with the control group, indicating that the synergistic treatment group had a higher inhibitory effect on the growth of melanoma, and its inhibition rate was as high as about 83%. These results are mainly because Cu(Ⅱ)-TCPP nanomaterials consume GSH in TME and catalyze hydrogen peroxide to produce more toxic ROS, thereby inducing tumor cell death. If the treatment continues, the tumor can be completely eliminated.

[0025] Table 1 below is a table showing the composition of the efficacy study of the B16-F10 model in C57BL / 6 mice:

[0026] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing a graded cryo-microneedle patch for delivering nano-drugs, comprising the following steps: Step S1: Preparation of nanomedicine: Porphyrin is selected as ligand, Cu 2+ ,Fe 3+ ,Co 2+ The metal atom is coordinated to form a metal porphyrin complex, TCPP is reacted with a metal salt, and the complex is prepared by solution synthesis or hydrothermal or solvothermal method; Step S2: Preparation of methacrylated gelatin GelMA hydrogel: ① Dissolve 5 g of gelatin in 50 mL of phosphate buffered saline (PBS) and stir at 50-70°C for 2-4 h; ② Add 10 mL of methacrylic anhydride (MA) solution to the above solution at a rate of 0.3-0.6 mL / min and stir at 40-60°C for 2-4 h; ③ Add 250 mL of room temperature phosphate buffer PBS to dilute all the mixtures to stop the methacrylic acidification reaction; finally, dialyze with a dialysis bag for 5 to 7 days; the deionized water was replaced every 12 hours, and the methacrylated gelatin GelMA hydrogel was successfully prepared; Step S3: Preparation of hierarchical methacrylated gelatin microneedle patches loaded with nanodrugs: ① Prepare a solution with a mass fraction of 0.32 wt% to 0.4 wt% by dissolving 4 to 5 mg of the nanodrug prepared in step S1 in 1.25 mL of the GelMA hydrogel solution prepared in step S2, and stir at a low temperature of 2 to 8°C until the mixture is uniformly stirred; ② Inject into the microneedle mold made of polydimethylsiloxane (PDMS), place it symmetrically in a 6-well plate, and then centrifuge at 3500 rpm for 5 min in a low-temperature shaker at 2-8°C. Rotate the 6-well plate 180° clockwise and centrifuge again to fill the needle tip with nanomedicine. Remove excess solution from the base with a pipette, and then add GelMA hydrogel solution to serve as the microneedle base. ③ Place the microneedle patch under 405 nm ultraviolet light for cross-linking for 2 to 5 minutes; ④Then place it in liquid nitrogen and freeze it for 15 to 30 minutes; ⑤ After demoulding, refrozen for 20 to 40 seconds; The microneedle patch prepared by the above steps is 1 cm square, with 11×11 microneedles with a height of 800 µm.

2. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 1, characterized in that: In the step S1, the preparation of Cu(II)-TCPP two-dimensional nanomedicine: ① Dissolve 80 mg of porphyrin in 40 mL of solution A and stir continuously until the solution becomes clear; The solution A is dimethylformamide DMF: normal hexane volume ratio = 3:1; ②Dissolve 400 mg CuCl2·2H2O in 40 mL anhydrous ethanol and stir for 10 minutes; ③ Mix the two solutions and stir for 20 to 40 minutes, then place them in a water bath at 80 to 90°C and stir for 10 to 15 hours; ④ Wash the solution alternately with anhydrous ethanol and deionized water for 3 times at 8000 rmp; ⑤ Perform ultrasonic peeling at 5-10°C for 1-2h, high-speed centrifugation for 15 min (12000 rmp), wash with deionized water 3 times, disperse it in deionized water, freeze it in a refrigerator for 6-10h, and freeze-dry it in a freeze dryer to obtain flaky Cu(Ⅱ)-TCPP nanomedicine.

3. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 2, characterized in that: The two solutions were mixed and stirred for 30 minutes and heated in a water bath at 85° C. for 12 h.

4. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 1, characterized in that: In the step S1, Fe-TCPP nanomedicine is prepared: ① Use dimethylformamide DMF as solvent to prepare three solutions: 4mL solution B: 60 mg FeCl3·6H20; 8 mL solution C: 20 mg porphyrin; 8 mL of solution D: 560 mg benzoic acid; ② Mix and stir the three prepared solutions for 30 min, and then place them in a water bath at 80-100°C and stir for 4-7 h; ③ After the reaction, the solution was centrifuged at high speed for 15 min (12000 rmp), washed with deionized water three times, and dispersed in deionized water.

5. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 4, characterized in that: The three solutions were mixed and stirred for 30 min and then placed in a 90 °C water bath and stirred for 5 h.

6. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 1, characterized in that: In the step S1, the preparation of Co-TCPP nanomaterials: ①Co(NO3)2·6H2O (16.16 mg), 2,2'-bipyridine BPY (6.2 mg) and PVP (40 mg) were completely dissolved in a mixture of dimethylformamide DMF (18 mL) and ethanol (6 mL), and the mixed solution was placed in a 50 mL glass bottle; ② TCPP (16 mg) was completely dissolved in a mixture of DMF (6 mL) and ethanol (2 mL), and then added dropwise to the above glass bottle; ③Ultrasonic treatment for 25-35 min, ④ Heat the mixture to 70-90°C and stir while maintaining the temperature for 20-24 hours; ⑤ After cooling to room temperature, the crude product was centrifuged and washed with ethanol three times, and the obtained Co-TCPP nanosheets were redispersed in ethanol.

7. The method for preparing nanomedicine delivered by graded cryo-microneedle patch according to claim 6, characterized in that: The ultrasonic treatment time was 30 min, and the mixture was heated to 80 °C and stirred for 24 h.

8. A graded cryo-microneedle patch for delivering nano-drugs prepared by the preparation method according to any one of claims 1 to 7.

9. An application of a hierarchical cryo-microneedle patch for delivering nano-drugs prepared by the preparation method according to any one of claims 1 to 7 in photochemical dynamic synergistic anti-tumor.